Maplelane Capital, LLC Abb Vie Inc. Put Options Transaction History

Maplelane Capital, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $17.1 Million - $21.8 Million	-260,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $20.1 Million - $23.6 Million	-260,000 Reduced 50.0%	260,000 $21 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $5.45 Million - $6.72 Million	70,000 Added 15.56%	520,000 $47.9 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $22.2 Million - $24.7 Million	250,000 Added 125.0%	450,000 $42.6 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $18 Million - $21.2 Million	200,000 New	200,000 $18.5 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Maplelane Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Maplelane Capital, LLC with notifications on news.